Clinical trial
Impact of Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer, During Treatment With Trastuzumab in Adjuvant
NCT02433067 is registered in ClinicalTrials.gov with University of Franche-Comté as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer, During Treatment With Trastuzumab in Adjuvant
- Lead sponsor
- University of Franche-Comté
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2015
- Completion date
- October 31, 2020
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer